Cargando…

Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease

This minireview provides current summaries of beta-blocker use in the management of hypertension and/or chronic kidney disease. Accumulated evidence suggests that atenolol is not sufficiently effective as a primary tool to treat hypertension. The less-than-adequate effect of beta-blockers in lowerin...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomiyama, Hirofumi, Yamashina, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941231/
https://www.ncbi.nlm.nih.gov/pubmed/24672712
http://dx.doi.org/10.1155/2014/919256
_version_ 1782305887898042368
author Tomiyama, Hirofumi
Yamashina, Akira
author_facet Tomiyama, Hirofumi
Yamashina, Akira
author_sort Tomiyama, Hirofumi
collection PubMed
description This minireview provides current summaries of beta-blocker use in the management of hypertension and/or chronic kidney disease. Accumulated evidence suggests that atenolol is not sufficiently effective as a primary tool to treat hypertension. The less-than-adequate effect of beta-blockers in lowering the blood pressure and on vascular protection, and the unfavorable effects of these drugs, as compared to other antihypertensive agents, on the metabolic profile have been pointed out. On the other hand, in patients with chronic kidney disease, renin-angiotensin system blockers are the drugs of first choice for achieving the goal of renal protection. Recent studies have reported that vasodilatory beta-blockers have adequate antihypertensive efficacy and less harmful effects on the metabolic profile, and also exert beneficial effects on endothelial function and renal protection. However, there is still not sufficient evidence on the beneficial effects of the new beta-blockers.
format Online
Article
Text
id pubmed-3941231
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-39412312014-03-26 Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease Tomiyama, Hirofumi Yamashina, Akira Int J Hypertens Review Article This minireview provides current summaries of beta-blocker use in the management of hypertension and/or chronic kidney disease. Accumulated evidence suggests that atenolol is not sufficiently effective as a primary tool to treat hypertension. The less-than-adequate effect of beta-blockers in lowering the blood pressure and on vascular protection, and the unfavorable effects of these drugs, as compared to other antihypertensive agents, on the metabolic profile have been pointed out. On the other hand, in patients with chronic kidney disease, renin-angiotensin system blockers are the drugs of first choice for achieving the goal of renal protection. Recent studies have reported that vasodilatory beta-blockers have adequate antihypertensive efficacy and less harmful effects on the metabolic profile, and also exert beneficial effects on endothelial function and renal protection. However, there is still not sufficient evidence on the beneficial effects of the new beta-blockers. Hindawi Publishing Corporation 2014 2014-01-30 /pmc/articles/PMC3941231/ /pubmed/24672712 http://dx.doi.org/10.1155/2014/919256 Text en Copyright © 2014 H. Tomiyama and A. Yamashina. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Tomiyama, Hirofumi
Yamashina, Akira
Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease
title Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease
title_full Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease
title_fullStr Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease
title_full_unstemmed Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease
title_short Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease
title_sort beta-blockers in the management of hypertension and/or chronic kidney disease
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941231/
https://www.ncbi.nlm.nih.gov/pubmed/24672712
http://dx.doi.org/10.1155/2014/919256
work_keys_str_mv AT tomiyamahirofumi betablockersinthemanagementofhypertensionandorchronickidneydisease
AT yamashinaakira betablockersinthemanagementofhypertensionandorchronickidneydisease